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Introduction. National efforts to curtail healthcare-associated 
infections (HAI) proliferated recently, though data detailing 
progress over time are limited. This retrospective cohort study 
aims to describe changes in incidence and antimicrobial suscep-
tibility of HAI in four New York City hospitals over seven years. 
Methods. Electronic data were collected retrospectively for all 
patients discharged from 2006 through 2012. Previously vali-
dated computerized algorithms based on National Healthcare 
Safety Network criteria detected bloodstream infections, pneu-
monia, surgical site infections, and urinary tract infections with 
Enterococcus spp., Staphylococcus aureus, Streptococcus pneu-
moniae, Acinetobacter baumannii, Pseudomonas aeruginosa 
and Klebsiella pneumoniae. Antimicrobial susceptibilities were 
obtained from electronic laboratory records. Logistic regression 
was used to assess changes in odds of acquiring an HAI and 
odds of antimicrobial resistance over time, controlling for age, 
gender, severity of illness, previous hospitalizations, and admis-
sion source. 
Results. In total, 19,052 HAI were identified among 761,426 
discharges. HAI rates fell for all organisms, all infection types, 
and within all hospitals. Odds of acquiring an HAI decreased 
significantly over time for all organisms. Resistance levels were 
stable for Enterococcus spp., S. aureus, A. baumannii, and S. 
pneumoniae. Multidrug resistance increased for P. aeruginosa 
and decreased for K. pneumoniae, though imipenem resistance 
among K. pneumoniae climbed sharply in 2011. 
Conclusions. This study suggests that HAI incidence rates are 
falling, possibly due to increased federal, state and local atten-
tion to healthcare quality and patient safety. Though we found 
no substantial reductions in resistance, recent national attention 
towards antimicrobial stewardship may precipitate a change in 
coming years.
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Introduction
Healthcare-associated infections (HAI) remain en-
demic in U.S. healthcare facilities despite growing 
emphasis on infection prevention and control programs 
designed to curtail their spread [1]. The latest national 
data released by the Centers for Disease Control and 
Prevention (CDC) National Healthcare Safety Network 
(NSHN) show notable decreases for some HAI in-
cluding central line-associated bloodstream infections 
(BSI) and certain types of surgical site infections (SSI) 
[2]. However, national longitudinal data are avail-
able only for the selected types of HAI tracked by the 
NHSN, which are limited primarily to procedure- and 
device-associated infections. The NHSN data also re-
veal substantial differences across regions and states, 
emphasizing the importance of monitoring trends at the 
local level [2].
Antimicrobial resistance among common healthcare 
pathogens is similarly persistent in hospitals, even 
with advances in stewardship efforts and transmission-
based precautions for patients with drug-resistant or-
ganisms [3-5]. Multidrug-resistant phenotypes are im-
plicated in more than 20% of HAI nationally, though 
prevalence varies considerably by region and institu-
tion [6]. The CDC’s most recent comprehensive report 
on antimicrobial susceptibilities shows only slight 
changes in resistance for most organisms over the past 
several years, but data are likewise limited to specific 
types of HAI and trends are evaluated for only a short 
time period [6].
In light of the need for longitudinal data at the local level 
following a period of sharp increases in regional Gram-
negative resistance, this study aims to describe changes 
in the epidemiology of HAI in four New York City hos-
pitals over a seven year period from 2006 through 2012. 
Specifically, this study assesses changes in incidence of 
HAI, prevalence of antimicrobial resistance, and patient-
level factors at admission that are associated with these 
outcomes for six of the most common bacterial patho-
gens in healthcare settings.
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Methods
Sample and setting
Data were collected from four hospitals in a single ac-
ademically-affiliated network located in New York, NY. 
The facilities included a 221-bed community hospital, 
a 283-bed pediatric acute care hospital, a 647-bed adult 
tertiary/quaternary care hospital, and a 914-bed adult 
and pediatric tertiary/quaternary care hospital. All dis-
charges occurring from January 1, 2006 through Decem-
ber 31, 2012 were included in the analyses. Although 
some patients were admitted multiple times throughout 
the seven-year study period, the unit of analysis for this 
study was each patient discharge.
Data collection
All data were collected retrospectively from the net-
work’s Clinical Data Warehouse, which stores infor-
mation from a variety of electronic sources shared by 
the four hospitals [7]. Dates of hospital admission and 
discharge, source of admission, and previous in-network 
hospitalizations were obtained from the admission-dis-
charge-transfer (ADT) record. Complete lists of Inter-
national Classification of Diseases, 9th Revision, Clini-
cal Modification (ICD-9-CM) diagnosis and procedure 
codes associated with each admission were obtained 
from billing records. Time-stamped culture results and 
antimicrobial susceptibility patterns were obtained from 
clinical microbiology laboratory records. All data were 
linked using patients’ unique medical record numbers 
and admission dates.
Definitions of infections, antimicrobial 
resistance, and patient characteristics
Four types of infections were included in this analysis: 
BSI, SSI, urinary tract infections (UTI), and pneumonia. 
Algorithms for identifying infections in the electronic 
data were designed in accordance with the NHSN guide-
lines for surveillance of HAI [8]. Figure 1 illustrates cri-
teria used to adjudicate cases of each infection type: BSI 
were identified by blood cultures; SSI by post-operative 
wound cultures and documentation of an NHSN operat-
ing room procedure; pneumonia by respiratory culture 
and ICD-9-CM diagnosis code for pneumonia; and UTI 
by either urine culture 103-105 colony forming units per 
milliliter (CFU/mL) and less than two other species and 
pyuria within a 48 hour window before or after culture 
collection, or urine culture with at least 105 CFU/mL and 
less than two other species.
Dates of culture collection and hospital admission were 
used to determine whether infections were healthcare-
associated, i.e., developed at least two days after hospital 
admission.
This study included HAI associated with Staphylococcus 
aureus, Acinetobacter baumannii, Streptococcus pneu-
moniae, Pseudomonas aeruginosa, Klebsiella pneumo-
niae, Enterococcus faecalis and Enterococcus faecium. 
Binary classifications of antibiotic resistance were de-
fined for S. aureus (oxacillin), S. pneumoniae (penicillin), 
A. baumannii (ampicillin-sulbactam), and E. faecalis and 
E. faecium (vancomycin). For P. aeruginosa we assessed 
resistance to cefepime, gentamicin, levofloxacin, mero-
penem, piperacillin/tazobactam, and tobramycin. For K. 
pneumoniae we assessed resistance to cefepime, ceftri-
axone, gentamicin, imipenem, levofloxacin, meropenem, 
piperacillin/tazobactam, tobramycin, and trimethoprim/
sulfamethoxazole. Multidrug resistance for P. aeruginosa 
and K. pneumoniae was defined as resistance to at least 
three antibiotic classes among those assessed [9]. Resist-
ance to each antibiotic was determined by the hospitals’ 
clinical microbiology laboratories.
Patient characteristics at admission were assessed us-
ing several measures. A weighted Charlson Comorbid-
ity Index was created using ICD-9-CM diagnosis codes 
for conditions indicated as being present upon hospital 
admission [10]. Patients who had at least one within-net-
work inpatient hospitalization in the previous year were 
identified using ADT records. In addition, ADT records 
were used to determine patients’ admission source, de-
fined as either healthcare (i.e., transfer from another hos-
pital, ambulatory surgery center, skilled nursing facility, 
hospice center) or non-healthcare (e.g., from home). Pa-
tient age, sex, admission hospital, and admission year 
were also collected from the Clinical Data Warehouse.
Statistical analysis
To assess changes in HAI over time we tabulated the 
number of HAI occurring each year and stratified by or-
ganism and body site of infection. Percent changes in 
HAI incidence per 10,000 discharges between 2006 and 
2012 were calculated. Multiple logistic regression was 
used to evaluate changes in odds of infection over time, 
controlling for hospital, age (continuous), sex, within-
network hospitalization in the previous year, admission 
source, and Charlson Comorbidity Index. A separate 
model was constructed for each of the six organisms. 
Patients who had an infection in more than one body 
site with the same organism during a single admission 
were represented only once in each multivariable model. 
In order to evaluate whether patient characteristics as-
sociated with HAI changed throughout the study period, 
we also assessed interaction between year and age, sex, 
prior hospitalization, admission source and Charlson 
Comorbidity Index for each body site of infection.
To assess changes in antibiotic sensitivities over time, we 
tabulated the annual proportion of infections resistant to 
each of the antibiotics identified a priori for each organ-
ism. Multiple logistic regression was used to evaluate 
changes in the odds of resistance over time, controlling 
for hospital, age, sex, within-network hospitalization in 
the previous year, admission source, and Charlson Co-
morbidity Index. Each organism was modeled separately. 
Patients who had an infection at more than one body site 
with the same organism during a single admission were 
represented only once in each multivariable model and 
were considered to have a resistant infection if at least one 
of the infections was caused by a resistant organism.
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Results
Characteristics of the 761,426 patient discharges that oc-
curred during the study period are described by year in 
Table I. A total of 19,052 HAI with the six organisms 
of interest were identified. Forty-nine percent were UTI 
(N  =  9,319), 23% were pneumonia (N  =  4,414), 19% 
were BSI (N = 3,602), and 9% were SSI (N = 1,717). 
From 2006 to 2012, incidence per 10,000 discharges fell 
for each type of HAI within all four hospitals and for 
each of the six organisms included in this study (Fig. 2). 
Table II displays results of the multivariable regression 
analyses modeling the association between advancing 
year and odds of HAI. For each organism there was a 
statistically significant decrease in the odds of HAI over 
time, controlling for hospital and patient characteristics. 
Patients with a healthcare admission source were signifi-
cantly more likely to develop an HAI with all organisms 
except S. pneumoniae, for which a positive but not sta-
tistically significant association was found. Within-net-
work hospitalization in the previous year significantly 
increased the odds of developing an HAI with all organ-
isms except S. pneumoniae, for which a statistically sig-
nificant negative association was found. Advancing age 
and greater severity of illness were significantly associ-
ated with development of HAI for all organisms. Male 
patients were significantly more likely to develop an 
HAI with S. aureus, P. aeruginosa, S. pneumoniae and 
A. baumannii, while female patients were significantly 
Tab. I. Characteristics of hospitalized patients by year.
Year 2006 2007 2008 2009 2010 2011 2012
N 104,645 106,783 105,177 109,631 112,656 112,122 110,412
% (no.) admitted to each hospital
Community 13.1 (13,668) 12.6 (13,476) 12.7 (13,376) 11.7 (12,803) 11.6 (13,072) 11.2 (12,557) 11.1 (12,225)
Pediatric acute care 15.8 (16,507) 17.1 (18,281) 18.0 (18,959) 15.2 (16,694) 14.6 (16,487) 14.5 (16,260) 14.9 (16,405)
Adult tertiary/quaternary care 31.9 (33,355) 31.7 (33,839) 31.4 (33,054) 31.9 (35,005) 32.2 (36,283) 31.7 (35,579) 31.3 (34,608)
Adult/pediatric tertiary/quaternary care 39.3 (41,115) 38.6 (41,187) 37.8 (39,788) 41.2 (45,129) 41.6 (46,814) 42.6 (47,726) 42.7 (47,174)
% (no.) admitted from healthcare source* 9.6 (10,044) 10.5 (11,228) 10.7 (11,287) 17.3 (18,983) 16.7 (18,798) 17.5 (19,653) 16.6 (18,270)
% (no.) hospitalized within previous year** 22.6 (23,658) 32.4 (34,601) 37.2 (39,069) 40.2 (44,054) 43.3 (48,772) 44.4 (49,747) 45.1 (49,800)
Mean (standard deviation) Charlson 
Comorbidity Index 1.4 (2.75) 1.6 (2.95) 1.6 (2.93) 1.6 (2.99) 1.7 (3.08) 1.8 (3.30) 1.8 (3.36)
Mean (standard deviation) age in years 44.5 (27.82) 44.3 (27.89) 44.4 (27.99) 44.6 (28.11) 44.8 (28.11) 45.5 (28.3) 45.4 (28.46)
% (no.) male sex 44.9 (46,989) 44.5 (47,511) 44.2 (46,473) 44.4 (48,717) 44.3 (49,930) 44.5 (49,939) 44.4 (48,989)
*Admission from another hospital, ambulatory surgery center, skilled nursing facility, or hospice center.
**Within-network hospitalizations only.
Fig. 1. Algorithms for identifying four types of infections using electronically available data from laboratory records and International Classifi-
cation of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure codes. Definitions are based on the Centers for Dis-
ease Control and Prevention National Healthcare Safety Network (NHSN) guidelines for surveillance of HAIs [7]. ICD-9-CM codes for pneumonia 
included 003.22, 020.3-020.5, 021.2, 022.1, 031.0, 039.1, 052.1, 055.1, 073.0, 083.0, 112.4, 114.0, 114.4, 114.5, 115.05, 115.15, 115.95, 130.4, 
136.3, 480.0-480.3, 480.8, 480.9, 481, 482.0-482.3, 482.30-482.32, 482.39, 482.4, 482.40, 482.41, 482.42, 482.49, 482.8, 482.81-482.84, 482.89, 
482.9, 483, 483.0, 483.1, 483.8, 484.1, 484.3, 484.5-484.8, 485, 486, 513.0, and 517.1. CFU/mL, colony forming units per milliliter.
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more likely to develop an HAI with K. pneumoniae and 
E. faecalis/E. faecium.
The impact of admission source and within-network hos-
pitalization in the previous year decreased significantly 
over time, with the magnitude of association between 
HAI and admission source decreasing steadily through-
out the study period and the magnitude of association 
between HAI and previous hospitalization decreasing 
steadily through 2010 and then rising slightly. Statisti-
cally significant interaction with year was not identified 
for any other factor.
The annual proportion of HAI caused by antibiotic-re-
sistant organisms is presented in Table III. The multivar-
iable logistic regression analyses show no appreciable 
change in levels of antibiotic resistance for any organism 
except P. aeruginosa, for which multidrug resistance in-
creased significantly over the study period and K. pneu-
moniae, for which multidrug resistance decreased sig-
nificantly (Table II). Resistance to all tested antibiotics 
increased for P. aeruginosa. For K. pneumoniae, resist-
ance decreased slightly for all tested antibiotics except 
for tobramycin, for which resistance increased by 10%, 
and imipenem, for which there was a sharp increase from 
an average of 20% in 2006-2010 to over 70% in 2011.
Patients with a healthcare admission source were signifi-
cantly more likely to develop a resistant infection for all 
organisms except S. pneumoniae and A. baumannii. Re-
sistance was significantly associated with within-network 
Tab. II. Relationships between advancing year and odds of healthcare-associated infection, odds of antimicrobial resistance at four New York 
City hospitals, 2006-2012.
Organism
Enterococcus 
faecalis and 
Enterococcus 
faecium
Staphylococcus 
aureus
Klebsiella 
pneumoniae
Pseudomonas 
aeruginosa
Acinetobacter 
baumannii
Streptococcus 
pneumoniae
Relationship between advancing year and odds of healthcare-associated infection1
N 6,301 4,399 4,116 2,758 688 195
Year (continuous, 2006-2012) 0.86 [0.85,0.87] 0.89 [0.88,0.90] 0.89 [0.87,0.90] 0.90 [0.88,0.92] 0.88 [0.85,0.92] 0.85 [0.79,0.92]
Hospital*
   Community 0.44 [0.40,0.48] 0.59 [0.52,0.66] 0.55 [0.49,0.63] 0.49 [0.42,0.56] 0.76 [0.56,1.02] 0.82 [0.49,1.36]
   Pediatric acute care 0.57 [0.51,0.65] 0.70 [0.61,0.79] 1.01 [0.86,1.17] 0.85 [0.71,1.02] 0.78 [0.54,1.13] 0.60 [0.32,1.13]
   Adult/pediatric tertiary/  
   quaternary care 
0.54 [0.51,0.57] 0.80 [0.75,0.86] 1.27 [1.20,1.36] 0.80 [0.74,0.87] 1.37 [1.15,1.61] 0.94 [0.69,1.30]
Healthcare admission 
source**
2.08 [1.96,2.21] 1.91 [1.78,2.05] 1.88 [1.75,2.02] 2.23 [2.05,2.43] 2.63 [2.23,3.10] 1.39 [0.96,2.00]
Hospitalized within previous 
year***
1.75 [1.66,1.85] 1.47 [1.39,1.57] 1.49 [1.40,1.59] 1.64 [1.52,1.78] 1.39 [1.19,1.63] 0.68 [0.50,0.93]
Charlson Comorbidity Index 
(continuous)
1.08 
[1.075,1.085]
1.08 [1.07,1.09] 1.08 [1.07,1.09] 1.06 [1.05,1.07] 1.08 [1.07,1.09] 1.08 [1.05,1.11]
Age in years (continuous) 
1.017 
[1.016,1.018]
1.009 
[1.007,1.010]
1.021 
[1.019,1.022]
1.022 
[1.020,1.024]
1.01 [1.007,1.014] 1.006 [1.00,1.01]
Male sex 0.87 [0.83,0.91] 1.57 [1.48,1.67] 0.81 [0.77,0.87] 1.11 [1.03,1.20] 1.42 [1.23,1.65] 1.84 [1.37,2.46]
Relationship between advancing year and odds of antimicrobial resistance for patients with healthcare-associated infections2
N (%) resistant 2,716 (43.1) 1,964 (44.7) 404 (9.8) 165 (5.6) 276 (40.1) 75 (38.5)
Year (continuous, 2006-2012) 0.98 [0.95,1.01] 0.94 [0.91,0.97] 0.86 [0.82,0.91] 1.45 [1.32,1.59] 0.95 [0.88,1.03] 0.86 [0.73,1.01]
Hospital*
   Community 0.61 [0.49,0.76] 1.30 [1.03,1.65] 0.63 [0.42,0.95] 0.48 [0.20,1.13] 0.98 [0.52,1.85] 0.88 [0.28,2.76]
   Pediatric acute care 0.40 [0.29,0.55] 1.34 [0.98,1.83] 0.17 [0.09,0.34] 0.34 [0.16,0.74] 0.11 [0.03,0.50] 0.67 [0.16,2.78]
   Adult/pediatric tertiary/
   quaternary care 
2.77 [2.46,3.11] 1.00 [0.87,1.14] 0.37 [0.29,0.47] 0.78 [0.55,1.12] 2.01 [1.42,2.84] 0.74 [0.36,1.53]
Healthcare admission 
source**
1.36 [1.21,1.54] 1.28 [1.10,1.48] 1.98 [1.58,2.49] 1.47 [1.04,2.08] 1.05 [0.74,1.49] 2.26 [0.97,5.27]
Hospitalized within previous 
year***
1.46 [1.31,1.63] 1.62 [1.42,1.84] 1.59 [1.28,1.98] 1.18 [0.84,1.66] 0.82 [0.59,1.14] 1.40 [0.70,2.79]
Charlson Comorbidity Index 
(continuous)
1.04 [1.03,1.05] 1.01 [1.00,1.03] 1.00 [0.98,1.03] 0.98 [0.94,1.03] 1.00 [0.96,1.04] 1.12 [1.03,1.21]
Age in years (continuous) 
1.002 
[0.999,1.005]
1.017 
[1.014,1.020]
0.99 [0.98,1.00] 0.98 [0.97,0.99] 1.00 [0.99,1.01] 0.99 [0.97,1.00]
Male sex 0.84 [0.75,0.93] 0.99 [0.87,1.13] 1.26 [1.02,1.56] 1.08 [0.78,1.49] 1.25 [0.91,1.73] 2.14 [1.11,4.14]
Results of logistic regression analyses controlling for hospital and patient characteristics.  Data are odds ratios (95% confidence intervals). 
1 N for each organism is less than the total incidence for each organism because some patients had infections with the same organism in multiple body 
sites.
2 Antimicrobial resistance was defined as resistance to: oxacillin for Staphylococcus aureus; penicillin for Streptococcus pneumoniae; ampicillin-sulbactam 
for Acinetobacter baumannii; vancomycin for Enterococcus faecalis and Enterococcus faecium; and ≥ 3 antibiotic classes for Pseudomonas aeruginosa 
and Klebsiella pneumoniae.  
* Reference: adult tertiary/quaternary care
**Admission from another hospital, ambulatory surgery center, skilled nursing facility, or hospice center.
***Within-network hospitalizations only.
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hospitalization in the previous year for K. pneumoniae, 
S.  aureus, and E. faecalis/E. faecium. Odds of resist-
ance were significantly higher for males among those 
infected with K. pneumoniae and S. pneumoniae and sig-
nificantly higher for females among those infected with 
E. faecalis/E. faecium. There was a small but significant 
positive association between severity of illness and resist-
ance among S. pneumoniae and E. faecalis/E. faecium 
infections. Advancing age was associated with resistance 
among S. aureus infections, while younger age was as-
sociated with resistance among P. aeruginosa infections. 
Discussion
Using data from four hospitals in a major metropolitan 
center, we observed persistent and statistically signifi-
cant declines in the incidence of healthcare-associated 
BSI, SSI, UTI, and pneumonia between 2006 and 2012. 
The reductions in BSI, SSI, and pneumonia paralleled 
trends tracked at the national level for selected conditions 
including central line-associated BSI, BSI with methicil-
lin-resistant S. aureus, ventilator-associated infections, 
and SSI following common orthopedic, cardiac, gas-
trointestinal, and gynecological procedures  [2,  11-13]. 
Though U.S. rates of catheter-associated UTI climbed 
in 2009-2012, our study sites continued to experience 
annual reductions of total UTI [2, 11].
The reduced incidence of HAI across the study institu-
tions is noteworthy, particularly in light of changes to the 
patient population which occurred in tandem. Though 
severity of illness remained stable over the course of 
the study, the proportion of patients admitted from other 
healthcare facilities and who had been hospitalized in-
network within the previous year increased considerably, 
rising from 23% to 45% and from 10% to 17%, respec-
tively. Patients who have had prolonged contact with the 
healthcare system tend to be more vulnerable to infection 
and more likely to enter the hospital already having been 
colonized with common healthcare-associated pathogens 
[14]. Yet, the observed reductions in HAI were robust de-
spite the demographic shift to include a higher burden of 
these patients.  In fact, the results of the interaction mod-
els indicate that rates of HAI are falling even more among 
patients who had previous healthcare exposures compared 
with other patients, suggesting that the overall decline in 
HAI may be due, in part, to a reduced risk among this sub-
set. Improved screening procedures for patients admitted 
from healthcare sources or with known history of hospi-
talization may have contributed to falling HAI rates, pos-
sibly because a higher proportion of infections that were 
present upon hospital admission would have been diag-
nosed within the first 48 hours and therefore not counted 
as HAI, or because interventions such as decolonization 
were effective at preventing HAI [15]. Similarly, the slight 
decrease in S. pneumoniae may be due to faster diagnosis 
Fig. 2. Annual incidence of healthcare-associated infections per 10,000 admissions in four New York City hospitals, 2006-2012. The percent 
decrease in infection rate between 2006 and 2012 is displayed for each organism.
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and appropriate classification as non-HAI, since these in-
fections are more likely to be acquired in the community. 
Changes in infection prevention practices at the study 
institutions such as hand hygiene improvement and im-
plementation of a central line care bundle may have con-
tributed to declining infection rates overall, though it is 
difficult to evaluate the impact of specific policies since 
they varied throughout the course of the study.
In addition to risk differences between patients with and 
without previous healthcare contact, we also identified 
risk differences based on gender. That male patients had 
higher odds of developing HAI caused by S. aureus, P. 
aeruginosa, S. pneumoniae and A. baumannii while fe-
male patients had higher odds of K. pneumoniae and E. 
faecalis/E. faecium may be related to the types of infec-
tions that these organisms are most likely to cause. For 
example, S. aureus is a common cause of bloodstream 
infections, which are more common in male patients, and 
E. faecalis/E. faecium have emerged as common causes of 
UTI, which are more common in female patients [16-18]. 
The fact that female patients were more likely to have a 
vancomycin-resistant strain of E. faecalis/E. faecium may 
be the result of previous antibiotic treatment for recurring 
UTI [19]. S. pneumoniae has been reported to occur more 
frequently among men, possibly due to higher rates of 
smoking and underlying conditions such as chronic heart 
and lung diseases [20]. Previous antibiotic treatment for S. 
pneumoniae and other causes of pneumonia may explain 
why resistance was found to be higher among men [21].
While the incidence of HAI was greatly reduced, little 
progress was made with regard to reducing antimicrobial 
resistance. The strongest trend occurred among P. aerugi-
nosa, for which resistance to aminoglycoside, carbapenem, 
cephalosporin, and fluoroquinolone antibiotics increased 
and beta-lactamase inhibitor activity decreased. The pro-
portion of multidrug-resistant P. aeruginosa isolates grew 
from less than 1% in 2006 to over 10% in 2012, and state-
wide data suggest that this upward trajectory has contin-
ued in recent years [22]. For K. pneumoniae we observed 
moderate decreases in resistance to aminoglycoside, cepha-
losporin, fluoroquinolone, and sulfonamide antibiotics as 
well as increased beta-lactamase activity, though resist-
ance to imipenem more than tripled in 2011 following 
an outbreak of carbapenem-resistant K. pneumoniae.  It’s 
likely that this outbreak contributed to the overall rise in K. 
pneumoniae infections that occurred in 2011 after several 
years of steadily falling rates.  The considerable uptick in 
carbapenem resistance is reflective of a national epidemic 
of K. pneumoniae carbapenemase, which first appeared in 
New York City in the early 2000s [23, 24]. Still, the percent 
of K. pneumoniae isolates that were multidrug-resistant 
was lower than statewide reports of 25% and decreased 
throughout the study period [22]. This discrepancy may be 
due to differences in the definition of multidrug resistance 
and the specific drugs for which antimicrobial activity was 
assessed. Similar to trends reported at the state and national 
levels, methicillin resistance among S. aureus remained rel-
atively stable after 2007, following precipitous declines in 
Tab. III. Changes over time in the proportion of healthcare-associated infections resistant to antibiotics, 2006-2012.
2006 2007 2008 2009 2010 2011 2012
% change in 
proportion 
of resistant 
infections,  
2006 to 2012
Enterococcus 
faecalis  
and 
Enterococcus 
faecium 
(N = 6,476)
483/1,120 
(43)
529/1,178 
(45)
361/927 
(39)
406/975 
(42)
425/897  
(47)
322/763 
(42)
279/616  
(45)
+ 5%
Staphylococcus 
aureus 
(N = 4,553)
346/735 
(47)
395/810 
(49)
282/647 
(44)
296/679 
(44)
295/624  
(47)
241/572 
(42)
192/486  
(40)
– 15%
Klebsiella 
pneumoniae 
(N = 4,237)
69/735  
(9)
118/782 
(15)
85/633 
(13)
29/477  
(6)
30/431  
(7)
37/570  
(7)
43/609  
(7)
– 22%
Pseudomonas 
aeruginosa 
(N = 2,859)
3/435  
(1)
7/426  
(2)
11/479  
(2)
35/430  
(8)
42/417  
(10)
34/361  
(9)
33/311  
(11)
+ 1,000%
Acinetobacter 
baumannii 
(N = 731)
34/109 
(31)
69/144  
(48)
69/125 
(55)
38/95  
(40)
32/81  
(40)
40/93  
(43)
24/84  
(29)
– 6%
Streptococcus 
pneumoniae 
(N = 196)
15/40  
(38)
21/43  
(49)
19/39  
(49)
2/15  
(13)
0/12  
(0)
10/23  
(43)
9/24  
(38)
0%
Total  
(N = 19,052)
950/3,174 
(30)
1,139/3,383 
(34)
827/2,850 
(29)
779/2,671 
(29)
824/2,462 
(33)
684/2,382 
(29)
580/2,130 
(27)
– 10%
Data are no. resistant isolates/no. total isolates (% resistant).  Antimicrobial resistance was defined as resistance to: oxacillin for Staphylococcus aureus; 
penicillin for Streptococcus pneumoniae; ampicillin-sulbactam for Acinetobacter baumannii; vancomycin for Enterococcus faecalis and Enterococcus 
faecium; and ≥ 3 antibiotic classes for Pseudomonas aeruginosa and Klebsiella pneumoniae.
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the previous decade [3, 6, 22, 25, 26]. Consistent with data 
available from the CDC, no meaningful changes in vanco-
mycin resistance among Enterococcus spp. occurred in the 
study facilities during the observed time frame [6, 22].
This study was conducted during a period of heightened 
attention toward HAI prevention [1]. The application of 
evidence-based practices and bundles coupled with the 
adoption of new reimbursement policies that reframed 
many healthcare-associated conditions as fully preventa-
ble events likely played a role in reducing HAI [27, 28]. 
However, since many changes to infection prevention 
practice have been introduced during the last decade, 
it is not feasible to isolate the effects of any single ini-
tiative.  Moreover, it is unlikely that any one factor was 
solely responsible for the reduction [29]. Analogous 
broad efforts towards reducing antimicrobial resistance 
among healthcare-associated pathogens were also intro-
duced during this timeframe. Antimicrobial stewardship 
programs may have had some effect with regard to halt-
ing the upward trends in resistance for many organisms; 
nonetheless, data suggest that they have not yet had much 
impact with regard to lessening the burden of resistance 
at the state or national level [6, 16, 30]. The evidence of 
such impact is likely to require longer periods of time 
than other practices associated with prevention of HAI.
One of the major strengths of this analysis is its applica-
tion of a consistent methodology for identifying HAI over 
time. Unlike other sources of longitudinal data, the elec-
tronic algorithms used to define infections in this study 
were not sensitive to changes in case definitions, infection 
prevention personnel training, or financial and regulatory 
incentives that may have altered reporting practices [31]. 
The algorithms were created and validated by an interdis-
ciplinary team that included an infectious disease physi-
cian, and infection prevention nurse, an epidemiologist, a 
database manager, and an IT systems manager with ex-
pertise in hospital administrative data [7, 32, 33]. Still, the 
gold standard for diagnosis of an infection is clinician ad-
judication after full chart review, and disadvantages to us-
ing electronic data sources have been identified [34]. The 
SSI algorithm was designed to include only infections 
associated with NHSN operative procedures, so infec-
tions resulting from other procedures were not identified. 
Previous studies have reported low sensitivity for some 
of the ICD-9-CM codes used to create the Charlson Co-
morbidity Index, though specificity is generally high [35]. 
Data on previous out-of-network hospitalizations were 
not available, and it is possible that some within-network 
hospitalizations were not captured due to erroneous as-
signment of new medical record numbers to patients who 
were readmitted within one year. This type of misclas-
sification, however, could only lessen the magnitude of 
the observed association between previous admission and 
odds of HAI.  As the quality and availability of electronic 
patient data improves, the validity of some data elements 
may have changed over time, though we are not aware 
of any specific changes to the way data were collected 
or recorded that would have affected the study variables.
In addition to issues of data quality, there are also some 
limitations to our statistical analyses. We were unable to 
account for previous use of antibiotics, which is a known 
risk factor for resistance and may also confound the as-
sociations between infection and prior hospitalization or 
admission from a healthcare source, since patients with 
previous healthcare contact may be more likely to have 
taken antibiotics [36]. In addition, the multivariable model 
predicting antimicrobial resistance for S. pneumoniae was 
not adequately powered to detect differences over time.
Conclusion
Overall, this study provides strong support for the obser-
vation that the incidence of HAI is falling and that the 
reduction in HAI is not limited to device and procedure-
associated infections. Although we were unable to meas-
ure the impact of any specific policy or practice changes 
due to the overlapping nature of their implementation, 
the reduction may be the result of increased federal and 
state attention to healthcare quality and patient safety. 
Accordingly, although we have yet to observe substantial 
reductions in antimicrobial resistance, the recent uptick in 
national attention towards antimicrobial monitoring and 
stewardship may precipitate a change in coming years.
Acknowledgements
This work was supported by a grant from the Nation-
al Institute of Nursing Research, National Institutes of 
Health (NR010822).
The authors have no conflicts of interest.
Authors’ contributions
B.C. performed the analysis and wrote the manuscript. 
J.L. collected, prepared, and managed the data. E.L. 
oversaw the project and advised on the study design, 
analysis, and manuscript preparation.
References
[1]  Kahn KL, Battles JB. Taking national action to prevent and eliminate 
healthcare-associated infections. Med Care 2014;52(2 Suppl 1):S1-3.
[2] Centers for Disease Control and Prevention. 2013 national and 
state healthcare-associated infections progress report. Available at: 
www.cdc.gov/hai/progress-report/index.html [Accessed 10/25/17].
[3] Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, 
Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Pe-
terson K, Clifford McDonald L. Vital signs: preventing antibiot-
ic-resistant infections in hospitals-United States, 2014. MMWR 
Morb Mortal Wkly Rep 2016;65:235-41.
[4] Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin 
Proc 2011;86:1113-23.
[5] Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline 
for isolation precautions: preventing transmission of infectious 
agents in healthcare settings. Available at: http://www.cdc.gov/
hicpac/pdf/isolation/Isolation2007.pdf [Accessed on 10/25/17].
[6] Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srini-
vasan A, Kallen A, Limbago B, Fridkin S. Antimicrobial-resist-
ant pathogens associated with healthcare-associated infections: 
CHANGING EPIDEMIOLOGY OF HAI
E301
summary of data reported to the National Healthcare Safety 
Network at the Centers for Disease Control and Prevention, 
2009-2010. Infect Control Hosp Epidemiol 2013;34:1-14.
[7] Apte M, Neidell M, Furuya EY, Caplan D, Glied S, Larson E. 
Using electronically available inpatient hospital data for re-
search. Clin Transl Sci 2011;4:338-45.
[8] Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance 
definition of health care-associated infection and criteria for 
specific types of infections in the acute care setting. Am J Infect 
Control 2008;36:309-32. 
[9] Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas 
ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-
Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, 
Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, ex-
tensively drug-resistant and pandrug-resistant bacteria: an in-
ternational expert proposal for interim standard definitions for 
acquired resistance. Clin Microbiol Infect 2012;18:268-81.
[10] D’Hoore W, Bouckaert A, Tilquin C. Practical considerations 
on the use of the charlson comorbidity index with administrative 
data bases. J Clin Epidemiol 1996;49:1429-33.
[11] Centers for Disease Control and Prevention. 2012 national and 
state healthcare-associated infections progress report. Avail-
able at: http://www.cdc.gov/HAI/pdfs/progress-report/hai-pro-
gress-report-2014.pdf [Accessed 10/25/17].
[12] Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Mor-
rell G, Pollock DA, Edwards JR. National Healthcare Safety 
Network (NHSN) report, data summary for 2010, device-asso-
ciated module. Am J Infect Control 2011;39:798-816.
[13] Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Mor-
rell GC, Pollock DA, Edwards JR. National Healthcare Safety 
Network (NHSN) report, data summary for 2009, device-asso-
ciated module. Am J Infect Control 2011;39:349-67.
[14] McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS. A system-
atic literature review and meta-analysis of factors associated 
with methicillin-resistant Staphylococcus aureus colonization 
at time of hospital or intensive care unit admission. Infect Con-
trol Hosp Epidemiol 2013;34:1077-86.
[15] Calfee DP, Salgado CD, Milstone AM, Harris AD, Kuhar DT, 
Moody J, Aureden K, Huang SS, Maragakis LL, Yokoe DS. 
Strategies to prevent methicillin-resistant Staphylococcus au-
reus transmission and infection in acute care hospitals: 2014 
update. Infect Control Hosp Epidemiol 2014;35:772-96.
[16] Cohen B, Choi YJ, Hyman S, Furuya EY, Neidell M, Larson 
E. Gender differences in risk of bloodstream and surgical site 
infections. J Gen Intern Med. 2013;28:1318-25.
[17] Swaminathan S, Alangaden GJ. Treatment of resistant en-
terococcal urinary tract infections. Curr Infect Dis Rep 
2010;12:455-64.
[18] Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, 
Edmond MB. Nosocomial bloodstream infections in US hos-
pitals: analysis of 24,179 cases from a prospective nationwide 
surveillance study. Clin Infect Dis. 2004;39:309-17.
[19] Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on 
nosocomial epidemiology of vancomycin-resistant enterococci. 
Antimicrob Agents Chemother 2002;46:1619-28.
[20] Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: 
epidemiology, risk factors, and clinical features. Semin Respir 
Crit Care Med 2005;26:563-74.
[21] Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant 
pneumococci: biological and epidemiologic evidence for the 
effectiveness of alternative interventions. Clin Microbiol Rev 
2000;13:588-601.
[22] Centers for Disease Control and Prevention.  Antibiotic resistance 
patient safety atlas. Available at: http://www.cdc.gov/hai/surveil-
lance/ar-patient-safety-atlas.html. [Accessed on 10/25/17].
[23] Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Land-
man D, Rahal JJ, Brooks S, Cebular S, Quale J. Emergence of 
carbapenem-resistant Klebsiella species possessing the class A 
carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 
beta-lactamases in New York City. Clin Infect Dis 2004;39:55-60. 
[24] Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-re-
sistant Enterobacteriaceae: epidemiology and prevention. Clin 
Infect Dis 2011;53:60-7.
[25] Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. 
Methicillin-resistant Staphylococcus aureus central line–asso-
ciated bloodstream infections in US intensive care units, 1997-
2007. JAMA 2009;301:727-36.
[26] Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison 
LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner 
W, Townes J, Fridkin S. National burden of invasive methicillin-
resistant Staphylococcus aureus infections, United States, 2011. 
JAMA Intern Med 2013;173:1970-8.
[27] Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke 
ER, Ellingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, 
Lo E, Marschall J, Mermel LA, Nicolle LE, Salgado CD, Bry-
ant K, Classen D, Crist K, Deloney VM, Fishman NO, Foster 
N, Goldmann DA, Humphreys E, Jernigan JA, Padberg J, Perl 
TM, Podgorny K, Septimus EJ, VanAmringe M, Weaver T, Wein-
stein RA, Wise R, Maragakis LL. A compendium of strategies to 
prevent healthcare-associated infections in acute care hospitals: 
2014 updates. Infect Control Hosp Epidemiol 2014;35:967-77.
[28] Lee GM, Hartmann CW, Graham D, Kassler W, Dutta Linn M, Krein 
S, Saint S, Goldmann DA, Fridkin S, Horan T, Jernigan J, Jha A. Per-
ceived impact of the Medicare policy to adjust payment for health 
care-associated infections. Am J Infect Control 2012;40(4):314-9.
[29] Climo MW. Decreasing MRSA infections: an end met by un-
clear means. JAMA 2009;301:772-3.
[30] Schulz LT, Fox BC, Polk RE. Can the antibiogram be used to 
assess microbiologic outcomes after antimicrobial stewardship 
interventions? A critical review of the literature. Pharmacother-
apy 2012;32:668-76.
[31] Klompas M. Is a ventilator-associated pneumonia rate of zero 
really possible? Curr Opin Infect Dis 2012;25:176-82.
[32] Landers T, Apte M, Hyman S, Furuya Y, Glied S, Larson E. A 
comparison of methods to detect urinary tract infections using 
electronic data. Jt Comm J Qual Patient Saf 2010;36:411-7.
[33] Apte M, Landers T, Furuya Y, Hyman S, Larson E. Comparison 
of two computer algorithms to identify surgical site infections. 
Surg Infect (Larchmt) 2011;12:459-64.
[34] van Mourik MS, Troelstra A, van Solinge WW, Moons KG, Bonten 
MJ. Automated surveillance for healthcare-associated infections: 
opportunities for improvement. Clin Infect Dis 2013;57:85-93.
[35] Quan H, Li B, Saunders LD, Parsons GA, Nilsson CI, Alibhai 
A, Ghali WA. Assessing validity of ICD-9-CM and ICD-10 ad-
ministrative data in recording clinical conditions in a unique 
dually coded database. Health Serv Res 2008;43:1424-41.
[36] Rao GG. Risk factors for the spread of antibiotic-resistant bac-
teria. Drugs 1998;55:323-30.
n Received on May 5, 2017. Accepted on October 28, 2017.
n Correspondence: Bevin Cohen, Columbia University School of Nurs-
ing, 630 West 168th Street, New York, NY 10032 USA - Tel. 212-342-
4111 - Fax 212-305-0722 - E-mail: bac2116@columbia.edu
